new treatments may stop the disease

It is assumed that Type 1 diabetes

affects about 90,000 people in Spain. This chronic illness which happens when pancreas synthesizes insufficiently insulin, hormone that maintains adequate levels blood sugar level.

This pathology has its origin autoimmunewhich means insulin factories destroyed for your organism.

Their symptoms appear in shape sudden and they can be: Constant thirst, unexplained weight loss, excessive urination, fatigue, weakness and blurred vision.

Read also

Andrea Reyes

His care consists of regulate glucose levels through injections or pumps continuous delivery of insulin.

However experts I agree that these methods do not provide satisfactory glycemic control for most people.

For this reason they note that it is important new treatments for type 1 diabetes.

The truth is that there is currently development of alternatives To insulinespecially so-called low-risk immunotherapy, which aims preserve beta cell function

therefore there is no need to administer the hormone.

As noted Colin Dayanmember Cardiff University Faculty of Medicine Diabetes and Autoimmunity Group in the UK, at a conference he gave at the XXXV National Congress of the Spanish Diabetes Society (SED), insulin and beta cell replacement using stem cells or transplantation could be considered as future How life-saving treatments reserved for late presentations.

Read also

Andrea Reyes

Moreover, he said that drug teplizumab approved for delay insulin administration between 2 and 3 years.

In this regard, the specialist said: “Without a doubt loss of insulin-producing cells can be delayed with low risk for patients, and in addition, we can now extend this period of “insulin-free type 1 diabetes” for a longer period.”

And he revealed: “There is at least seven other drugs that also have beneficial effects and they should be able to extend this period even further.”

Teplizumab has already been approved in USAbut it is not yet available in Spain because it does not have Approval from the European Medicines Agency (EMA).

This medicine is monoclonal antibody

created for interfere with the progression of type 1 diabetes which acts mainly on T cells which form the most important part body’s defense system.

Just as it is useful for people with prediabetes, Taking Teplizumab may cause Side effects How: hypoglycemia, skin rash, lymphopenia, headache, nausea and vomiting.

This drug may also cause more serious problems, although less frequently, such as cytokine release syndrome or infection.

Currently, this drug is only approved for those who have high risk of developing type 1 diabetes to delay its progression, but it is not yet indicated for those who have been diagnosed with this condition.

For this reason, experts note that the next stage may be treatment that does not include injections containing insulin.

This information in no way replaces a doctor’s diagnosis or prescription. It is important to consult a specialist when symptoms appear and never self-medicate.